|
Health Briefs
April
12, 2002
by Robert A. Wascher, M.D., F.A.C.S.
FISH & OMEGA-3 FATTY ACID CONSUMPTION
AND CARDIAC HEALTH
Two new studies add further evidence that the consumption of fish, or
fish oil supplements, can improve the health of your heart.
In the Journal of the American Medical
Association this week, the dietary habits of nearly 85,000 women
enrolled in the long-term Nurses’ Health Study were evaluated and compared
with the incidence of coronary heart disease in that group.
Over the course of 14 years, the study’s
participants were periodically surveyed and examined for interval changes
in their health (none of the volunteers had known heart disease upon
entering the study). The respondents were then categorized according
to the amount of fish or omega-3 fatty acid supplements in their diet.
In the group that consumed fish 5 or more times per week, the likelihood
of developing heart disease was 34% less than those who rarely ate fish.
Eating fish 2 to 4 times per week reduced
the risk of heart disease by 31%, and even eating fish 1 to 3 times
per month reduced the risk of heart disease by 29%.
Among women taking supplements of omega-3
fatty acids (the substance in fish that is thought to protect the heart),
those taking the highest amounts had a 33% reduction in heart disease
risk, while those taking lesser amounts still experienced a significant
benefit.
In those volunteers eating fish 5 or
more times per week or taking the highest amounts of omega-3 fatty acids,
the risk of dying from coronary heart disease was reduced by a very
substantial 45%.
This study is particularly important,
as previous studies involving fish and omega-3 fatty acid consumption
and their effects on heart disease have all confined their assessments
to men.
While retrospective dietary surveys
can suffer from lack of reliability, the power of this study is very
high due to the large number of study participants and the carefully
controlled conditions of the study.
RELATED
A related study, the Physicians’ Health
Study, has been following more than 22,000 physician volunteers
over the past 17 years.
In this week’s New England Journal
of Medicine is a report on the impact of omega-3 fatty acid supplements
on the risk of sudden cardiac death in this study group, all of whom
were without known heart disease.
The study’s authors tested the blood
of 94 male study volunteers who experienced an episode of sudden cardiac
death (but in whom there was no prior history of heart disease) and
184 matched control study participants who did not experience any cardiac
events.
Among the men with the highest levels
of omega-3 fatty acids in the blood, there was a 72% reduction in the
risk of experiencing sudden cardiac death when compared to the men with
the lowest levels of these substances in their blood.
The reasons for the protective effects
of omega-3 fatty acids are unclear at this time, although there is some
evidence that these nutrients can suppress the abnormal electrical rhythms
in the heart that can lead to sudden cardiac death. Omega-3 fatty acids
are also thought to reduce the levels of the “bad cholesterol” (LDL)
in the blood, which is thought to be the primary basis of their coronary
heart disease protective effect.
Importantly, both of these studies involved
volunteers who initially had no evidence of active coronary heart disease,
and encompassed many years of careful follow-up. These two factors make
their results especially compelling. However, large doses of omega-3
fatty acids can adversely affect the body’s clotting system, and may
increase the risk of bleeding in patients with underlying clotting abnormalities,
or in those patients taking certain medications such as anti-inflammatory
medications (e.g., aspirin, Motrin, Naprosyn, Indocin, Vioxx, Celebrex,
etc.) or blood thinners (e.g., Coumadin, Lovenox, etc.).
At the same time, concerns about the
widespread contamination of commercially harvested fish with mercury
and other potentially harmful substances may be a compelling reason
to consider omega-3 fatty acid supplements. As always, one should first
discuss changes in diet and dietary supplements with one’s physician.
BRIEFLY…
According to the Centers for Disease Control, the costs associated with
smoking in the United States exceed $150 billion each year, a 50% increase
over previous estimates. Smoking-induced
illness and lost productivity account for most of this gargantuan expense.
On the average, smoking reduces
the lifespan of women by 14.5 years, and by 13.2 years for men.
Nearly half a million Americans die
prematurely from tobacco-related diseases every single year, making
tobacco the single greatest cause of preventable disease and death in
our country today….
In the New England Journal of Medicine,
a new study has found that circumcision in men reduces the risk of infection
with the human papilloma virus (HPV) by 63% in men, and by 58% in women
whose partners were circumcised.
Although many compelling arguments have
been made against routine infant circumcision, this study is important
to consider, as virtually all cases of cervical cancer are thought to
be caused by chronic HPV infection of the cervix….
The Journal of the National Cancer
Institute reports on a study of the implications of race and socioeconomic
status on breast cancer treatment and survival. Previous studies have
shown that African American women are less likely to receive treatment
for breast cancer, and are more likely to die of the disease, when compared
to Caucasian women. After evaluating 5,719 women who developed breast
cancer in Michigan, the study concluded that socioeconomic status, and
not race, was the primary determinant of delayed diagnosis and poorer
survival….
The Journal of the American Medical
Association reports that St. John’s Wort, an over-the-counter “supplement”
used by many Americans and Europeans to treat depression, appears to
be ineffective in treating major depression when compared with Zoloft,
a prescription antidepressant that has been shown to be very effective
in treating moderate-to-severe depression.
Dr. Robert A. Wascher
Dr. Robert A. Wascher
is a senior research fellow in molecular & surgical oncology at the John
Wayne Cancer Institute in Santa Monica, CA
|